| A Study of Pegasys (Peginterferon Alfa-2a) Added to Nucleos(t)Ide Analogue Treatment in Participants With HBeAg-Negative Chronic Hepatitis B Genotype D Showing Stable Hepatitis B Virus (HBV) Deoxyribonucleic Acid (DNA) Suppression (NCT01706575) | Hoffmann-La Roche | 2013-01-01 |
| Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC) (NCT02759601) | Queen Mary University of London | 2013-01-01 |
| Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation (NCT01714310) | University of California, Los Angeles | 2013-01-01 |
| A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease (NCT01766336) | OPKO Health, Inc. | 2013-01-01 |
| Feasibility Study of IV Recombinant Tissue Plasminogen Activator (rtPA) vs. Primary Endovascular Therapy for Acute Ischemic Stroke (NCT01869478) | Mayo Clinic | 2013-01-01 |
| A Phase I/IIa Sporozoite Challenge Study to Assess the Efficacy of Candidate Combination Malaria Vaccine Approaches Using the ChAd63 and MVA Vectors Encoding the Antigens ME-TRAP, CS and AMA1 (NCT01739036) | University of Oxford | 2013-01-01 |
| A Program to Protect Young Children From Tobacco Smoke Exposure (NCT01335178) | Tel Aviv University | 2013-01-01 |
| EPI-743 in Cobalamin C Defect: Effects on Visual and Neurological Impairment (NCT01793090) | Bambino Gesù Hospital and Research Institute | 2013-01-01 |
| 12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI) (NCT02025179) | Northwestern University | 2013-01-01 |
| N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder (NCT01797575) | The University of Texas Health Science Center, Houston | 2013-01-01 |
| The Safety and Efficacy of Intralymphatic Immunotherapy in Pollen Allergic Adolescents and Young Adults With Asthma (NCT03394508) | Karolinska Institutet | 2013-01-01 |
| Dietary Intervention Replacing Carbohydrate With Protein and Fat Has Greater Effect on Peripheral Blood Mononuclear Cell Metabolites Than on Plasma Metabolites in Patients With Prediabetes or Type-2 Diabetes (NCT02191644) | Yonsei University | 2013-01-01 |
| Influence of Corticoids on Renal Function in Cardiac Surgery (NCT00879931) | University Hospital, Ghent | 2013-01-01 |
| A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens (NCT01762514) | Sun Yat-sen University | 2013-01-01 |
| Dexmedetomidine vs. Remifentanil for Pre-eclampsia During Caesarean Delivery (NCT01766089) | Mansoura University | 2013-01-01 |
| Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections (NCT02113332) | Vastra Gotaland Region | 2013-01-01 |
| Phase II Study of Gemcitabine+Romidepsin in the Relapsed/Refractory Peripheral T-cell Lymphoma Patients (NCT01822886) | Fondazione Italiana Linfomi - ETS | 2013-01-01 |
| Glucose Oxidase as Treatment Against Common Cold (NCT01883440) | Krister Tano | 2013-01-01 |
| ImmunoTEP for Patients With Medullary Thyroid Carcinoma. (NCT01730638) | Nantes University Hospital | 2013-01-01 |
| Exploratory Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity (NCT01831817) | GlaxoSmithKline | 2013-01-01 |
| Dose-finding and Safety of 2 Intradermal MEN-ACYW135-conjugate Vaccines (NCT01782066) | Leiden University Medical Center | 2013-01-01 |
| Proof of Biological Activity of SAR100842 in Systemic Sclerosis (NCT01651143) | Sanofi | 2013-01-01 |
| A Multicenter Phase 2 Study of Ibrutinib in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) With 17p Deletion (NCT01744691) | Pharmacyclics LLC. | 2013-01-01 |
| Functional Applications of Hyperpolarized 129Xe MRI (NCT01697332) | Brigham and Women's Hospital | 2013-01-01 |
| DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer (NCT01763931) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-01-01 |
| Mesenchymal Stem Cells to Treat Type 2 Diabetes (NCT02302599) | Chinese PLA General Hospital | 2013-01-01 |
| Safety and Efficacy of Liposomal Latanoprost in Ocular Hypertension (NCT01987323) | Singapore Eye Research Institute | 2013-01-01 |
| Oral Azithromycin Versus Doxycycline in Posterior Blepharitis (NCT01783860) | Tehran University of Medical Sciences | 2013-01-01 |
| Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease (NCT02689986) | Helse Fonna | 2013-01-01 |
| Effect of TTFields (150kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-5 Brain Metastases Following Optimal Standard Local Treatment (COMET) (NCT01755624) | NovoCure Ltd. | 2013-01-01 |
| Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine (NCT01848873) | Shenzhen Ausa Pharmed Co.,Ltd | 2013-01-01 |
| Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study (NCT02620618) | Cairo University | 2013-01-01 |
| Meditation-CBT for Opioid-treated Chronic Low Back Pain (NCT01775995) | University of Wisconsin, Madison | 2013-01-01 |
| Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer (NCT01815307) | Kansai Hepatobiliary Oncology Group | 2013-01-01 |
| Alveolar Recruitment Maneuver During Cesarean Section Improves Lung Compliance (NCT01826968) | General Hospital Of Pyrgos | 2013-01-01 |
| Randomised Trial in Waldenstrom's Macroglobulinaemia (NCT01592981) | University College, London | 2013-01-01 |
| Clinical Trial to Evaluate the Efficacy and Safety of DA-8031 in Male Patients With Premature Ejaculation (NCT01798667) | Dong-A Pharmaceutical Co., Ltd. | 2013-01-01 |
| A Study to Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI (NCT01763307) | Hadassah Medical Organization | 2013-01-01 |
| Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy (NCT01676961) | NYU Langone Health | 2013-01-01 |
| Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders (NCT02249676) | Tianjin Medical University General Hospital | 2013-01-01 |
| Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery (NCT01731730) | Adynxx, Inc. | 2013-01-01 |
| Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial (NCT01781637) | Boston Children's Hospital | 2013-01-01 |
| Dabrafenib Alone and in Combination With Trametinib Before Surgery in Treating Patients With Locally or Regionally Advanced Melanoma That Can Be Removed By Surgery (NCT01701037) | Vanderbilt-Ingram Cancer Center | 2013-01-01 |
| Transcutaneous Tibial Nerve Stimulation of Patients With Overactive Bladder (OAB) Syndrome (NCT02790307) | University College, London | 2013-01-01 |
| An Open-label, Multicenter, Phase II Study of Dovitinib in Advanced Thyroid Cancer (NCT01964144) | Yonsei University | 2013-01-01 |
| Bipolar Androgen-based Therapy for Prostate Cancer (BAT) (NCT01750398) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-01-01 |
| Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease (NCT01765660) | Nanfang Hospital, Southern Medical University | 2013-01-01 |
| Study of 89Zr-DFO-MSTP2109A in Patients With Prostate Cancer (NCT01774071) | Memorial Sloan Kettering Cancer Center | 2013-01-01 |
| Effect of Insulin Sensitizer Metformin on AD Biomarkers (NCT01965756) | University of Pennsylvania | 2013-01-01 |
| Assessment of Different Rehabilitation Treatments After a Partial Removal of the Meniscus (NCT01775345) | University Rovira i Virgili | 2013-01-01 |
| Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery (NCT01859182) | National Cancer Institute (NCI) | 2013-01-01 |
| Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting (NCT01755416) | Albert Einstein College of Medicine | 2013-01-01 |
| Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel (NCT01668459) | Dr Anjali Zarkar | 2013-01-01 |
| Oral Zinc Gluconate as Treatment for Recalcitrant Cutaneous Warts: A Randomized, Double-blind, Placebo-controlled Trial (NCT01783353) | Philippine Dermatological Society | 2013-01-01 |
| NOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors (NCT01718847) | National OncoVenture | 2013-01-01 |
| Study to Assess the Efficacy and Safety of SKI3246 in Subjects With Non-Constipation Irritable Bowel Syndrome (NCT02079675) | SK Chemicals Co., Ltd. | 2013-01-01 |
| Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant (NCT01754389) | Dana-Farber Cancer Institute | 2013-01-01 |
| Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma (NCT01861301) | National Cancer Institute (NCI) | 2013-01-01 |
| First Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple Myeloma 02 (NCT01790737) | Kuopio University Hospital | 2013-01-01 |
| Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With Spinal Cord Injury (NCT01769872) | R-Bio | 2013-01-01 |
| Afatinib vs Erlotinib as 2nd TKI After Failure to 1st TKI and Chemotherapy for Metastatic NSCLC (NCT02625168) | The University of Hong Kong | 2013-01-01 |
| Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574) (NCT01615874) | Organon and Co | 2013-01-01 |
| Trial of Artemether-Lumefantrine Alone and in Combination With Ivermectin to Reduce Post-Treatment Malaria Transmission (NCT01603251) | London School of Hygiene and Tropical Medicine | 2013-01-01 |
| Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer (NCT01776008) | National Cancer Institute (NCI) | 2013-01-01 |
| Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018) (NCT01453634) | OPKO Health, Inc. | 2013-01-01 |
| Lenalidomide, MTX, Ara-C and Rituximab in Relapsed Aggressive B-cell Lymphomas (NCT01788189) | University Hospital, Essen | 2013-01-01 |
| Thalidomide in Treating Crohn's Disease (NCT02501291) | First Affiliated Hospital, Sun Yat-Sen University | 2013-01-01 |
| Early Goal Directed Therapy for Acute Kidney Injury (NCT00306059) | University Hospital, Ghent | 2013-01-01 |
| Assessment of Photopill Capsule Treatment for Safety and Feasibility in Ulcerative Proctitis (NCT01837615) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2013-01-01 |
| Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia (NCT01728064) | PTC Therapeutics | 2012-12-31 |
| A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD) (NCT01674361) | Hoffmann-La Roche | 2012-12-31 |
| Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer (NCT02459652) | Japan Adjuvant Study Group of Pancreatic Cancer | 2012-12-28 |
| Efficacy and Safety Study of Ozanimod in Ulcerative Colitis (NCT01647516) | Celgene | 2012-12-26 |
| Efficacy and Safety of Nilotinib in Patients With a Chronic Disease of the Graft Against the Host (NCT02891395) | University Hospital, Lille | 2012-12-24 |
| Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies (NCT01760655) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-12-24 |
| BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer (NCT02783794) | Meabco A/S | 2012-12-24 |
| Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma (NCT01730950) | Radiation Therapy Oncology Group | 2012-12-20 |
| Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop) (NCT01698905) | Novartis Pharmaceuticals | 2012-12-20 |
| Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma (NCT01753713) | Manmeet Ahluwalia, MD | 2012-12-20 |
| LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer (NCT01685138) | Novartis Pharmaceuticals | 2012-12-20 |
| Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis (NCT01753076) | GlaxoSmithKline | 2012-12-20 |
| A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease (NCT01767311) | Eisai Inc. | 2012-12-20 |
| Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis , (NCT01526889) | Novartis Pharmaceuticals | 2012-12-20 |
| Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes (NCT01729845) | Fred Hutchinson Cancer Center | 2012-12-20 |
| BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC) (NCT01750918) | Novartis Pharmaceuticals | 2012-12-19 |
| Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma (NCT01729338) | Duke University | 2012-12-19 |
| Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia (NCT01736943) | Joseph Tuscano | 2012-12-19 |
| Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A (NCT01858922) | Baylor College of Medicine | 2012-12-19 |
| Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment. (NCT01750281) | AstraZeneca | 2012-12-18 |
| A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study (NCT01609933) | AbbVie (prior sponsor, Abbott) | 2012-12-18 |
| 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy (NCT01751451) | Memorial Sloan Kettering Cancer Center | 2012-12-18 |
| Pilot Study to Determine Effects of the Btk Inhibitor PCI-32765 on Leukemia Cell Kinetics and Trafficking, Using Heavy Water Labeling in Subjects With CLL and SLL (NCT01752426) | M.D. Anderson Cancer Center | 2012-12-17 |
| Deficits in Emotion Regulation Skills as a Maintaining Factor in Binge Eating Disorder (NCT03717493) | Friedrich-Alexander-Universität Erlangen-Nürnberg | 2012-12-17 |
| FST-100 in the Treatment of Acute Adenoviral Conjunctivitis (NCT01470664) | Shire | 2012-12-17 |
| Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer (NCT01631552) | Gilead Sciences | 2012-12-17 |
| Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration (NCT01736592) | Sanofi | 2012-12-14 |
| A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients (NCT01753167) | Genentech, Inc. | 2012-12-14 |
| Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer (NCT01619813) | Canadian Cancer Trials Group | 2012-12-14 |
| Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21 (NCT01714908) | Jinming Yu | 2012-12-14 |
| PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children (NCT01734512) | University of California, San Francisco | 2012-12-13 |